KNOWLEGDE AND ATTITUDE (or) PERCEPTIONS TOWARDS PHARMACOGENOMICS AMONG MEDICAL STUDENTS AND HEALTH CARE PROVIDERS IN A TERTIARY CARE HOSPITAL
Abstract
Abstract : BACKGROUND - Pharmacogenomics,
the science that deals with the
study of role of inheritance in the variation
in drug response, serves to be a valuable
tool in personalising therapy, thereby enhancing
therapeutic efficacy and reducing
adverse events. Knowledge and awareness
is required among the medical fraternity
for its appropriate application.
OBJECTIVES - To assess the knowledge
and attitude (or) perceptions towards
pharmacogenomics among medical students
and health care providers of Madras
Medical College and Rajiv Gandhi Government
General Hospital, Chennai-
3.METHODS - A survey was conducted
using a semi-structured questionnaire
among under-graduate and post-graduate
medical students, interns and physicians
comprising of 50 participants in each category.
Their knowledge were rated based
on a scale and the attitudes analysed. RESULTS
- Of all the study participants, only
3 percent of them had a good knowledge
in pharmacogenomics. 40 percent were
rated to have average,
53.5 percent had poor and 3.5 percent
had very poor knowledge. Majority of
them (65 percent) felt it was ethical to perform
genome sequencing before pharmacotherapy
and 78 percent were of the
opinion that it was required for the Indian
scenario. The most commonly reported
barrier for pharmacogenomic implementation
was economic constraints (52 percent)
and others such as lack of awareness,
laboratory facilities and ethical issues.
Most (78 percent) of them were in
favour of extensive incorporation of pharmacogenomic
information in the medical
curricula.CONCLUSION - The current
prevailing knowledge in pharmacogenomics
among medical students and healthcare
providers is inadequate and various
barriers limiting its implementation need to
be overcome to aid in optimising drug
therapy.
Keyword : Pharmacogenomics, Knowledge,
Attitude, Healthcare providers,
Medical students.
Full Text:
PDFReferences
Vesell ES. Pharmacogenetic perspectives
gained from twin and family studies. Pharmacol
Ther 1989;41:535-552.
Kalow W. Pharmacogenetics: heredity and
the response to drugs. Philadelphia: W.B.
Saunders, 1962.
Price Evans DA. Genetic factors in drug
therapy: clinical and molecular pharmacogenetics.
Cambridge, England: Cambridge University
Press, 1993.
Weber WW. Pharmacogenetics. New York:
Oxford University Press, 1997.
Kalow W, Tang BK, Endrenyi I. Hypothesis:
comparisons of inter- and
intra-individual variations can substitute
for twin studies in drug research.
Pharmacogenetics 1998;8:283-289
) W a n g L ( 2 0 1 0 ) .
"Pharmacogenomics: a systems approach".
Wiley Interdiscip Rev Syst
Biol Med 2 (1): 3–22. doi:10.1002/
wsbm.42. PMID 20836007.
MaryV.Relling and Kathleen
M.Giacomini.Pharmacogenetics;Laure
nce Brunton, Bruce Chabner,
BjornKnollman, Goodman & Gilman’s
The Pharmaceutical Basis of Therapeutics
th Edition. Mcgraw-Hill;2011.
pg:145-168.
McLeod HL, Evans WE. Pharmacogenomics:
unlocking the human genome
for better drug therapy. Annu
Rev Pharmacol Toxicol 2001;41:101-
Hart SN, Wang S, Nakamoto K,
Wesselman C, Li Y, Zhong XB
(January 2008). "Genetic polymorphisms
in cytochrome P450 oxidoreductase
influence microsomal P450-
catalyzed drug metabolism". Pharmacogenet.
Genomics 18 (1): 11–24.
doi:10.1097/FPC.0b013e3282f2f121.
Becquemont L (June 2009).
"Pharmacogenomics of adverse drug
reactions: practical applications and
perspectives". Pharmacogenomics 10
(6): 961–9. doi:10.2217/pgs.09.37
The U.S. Department of Energy
Genome Program's Biological and Environmental
Research Information
S y s t e m ( B E R I S ) : h t t p : / /
genomics.energy.gov.12) Rogausch A, Prause D, Schallenberg A,
Brockmöller J, Himmel W. Patients' and physicians'
perspectives on pharmacogenetic
testing. Pharmacogenomics 7(1), 49–59
(2006).
Dodson, Crystal ,Knowledge and attitudes
concerning pharmacogenomics
amonghealthcare professionals, : Personalized
Medicine, Volume 8, Number 4, July
, pp. 421-428(8)
Crystal Dodson; Marcia Van
Riper,Analysis of Clinicians' Attitudes Towards
Pharmacogenomics, Personalized Medicine.
;8(5):533-540.
Refbacks
- There are currently no refbacks.
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
An Initiative of The Tamil Nadu Dr M.G.R. Medical University